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Abstract
Background: Berberine is a plant alkaloid that is widely used as an anti-infective in traditional medicine. Escherichia coli
exposed to berberine form filaments, suggesting an antibacterial mechanism that involves inhibition of cell division.
Berberine is a DNA ligand and may induce filamentation through induction of the SOS response. Also, there is biochemical
evidence for berberine inhibition of the cell division protein FtsZ. Here we aimed to assess possible berberine mechanism(s)
of action in growing bacteria using genetics tools.
Methodology/Principal Findings: First, we tested whether berberine inhibits bacterial growth through DNA damage and
induction of the SOS response. The SOS response induced by berberine was much lower compared to that induced by
mitomycin C in an SOS response reporter strain. Also, cell filamentation was observed in an SOS-negative E. coli strain. To
test whether berberine inhibits FtsZ, we assessed its effects on formation of the cell division Z-rings, and observed a
dramatic reduction in Z-rings in the presence of berberine. We next used two different strategies for RNA silencing of ftsZ
and both resulted in sensitisation of bacteria to berberine, visible as a drop in the Minimum Inhibitory Concentration (MIC).
Furthermore, Fractional Inhibitory Concentration Indices (FICIs) showed a high level of synergy between ftsZ silencing and
berberine treatment (FICI values of 0.23 and 0.25 for peptide nucleic acid- and expressed antisense RNA-based silencing of
ftsZ, respectively). Finally, over-expression of ftsZ led to a mild rescue effect in berberine-treated cells.
Conclusions: The results argue against DNA binding as the primary mechanism of action of berberine and support the
hypothesis that its antibacterial properties are due to inhibition of the cell division protein FtsZ. In addition, the genetic
approach used here provides a means to rapidly test the activity of other putative FtsZ inhibitors.
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Introduction
Berberine (Figure 1) is an alkaloid produced by several plant
species including barberry (Berberis spp.) and goldenseal (Hydrastis
spp.), and is usually found in roots, stems and bark. Berberine has
been shown to exhibit antibacterial activity against a variety of
bacteria, including many pathogenic species and multidrug-
resistant (MDR) strains of M. tuberculosis and MRSA. It is also
active against some fungi and protozoans. Berberine is used in
traditional Chinese, Native American and also in Western
medicine, where it is recognised for its antimicrobial properties.
In addition, recent studies have revealed tumoricidal and anti-
inflammatory activities of the compound [1–9]. Berberine is a
relatively weak antimicrobial, especially against Gram-negative
bacteria. This is due to it being a substrate for the multi-drug
resistance efflux pumps; the presence of MDR pump inhibitors
remarkably increases the antibacterial effectiveness of the
compound [10]. Despite much data for its antimicrobial activity,
the mechanism of action of berberine in bacteria has remained
unclear.
A number of studies demonstrate that berberine is a DNA
ligand, able to bind both single- and double-stranded DNA in vitro
[11–14]. Thus, berberine binding to DNA in bacteria could lead
to DNA damage. If so, berberine would induce the bacterial SOS
response - a multi-level post-replication DNA repair system. The
SOS response involves over 20 genes and is regulated by LexA and
RecA. Its purpose is, firstly, to detect DNA damage, activate repair
mechanisms like NER (Nucleotide Excision Repair) and, if
necessary, to prevent cell division through binding of FtsZ by
SulA, resulting in cell elongation. This gives the cell time to repair
DNA lesions by inducing a further repair mechanism involving the
mutagenic DNA repair polymerase V.
An alternative possible mechanism of action for berberine was
reported in a recent study [2] that provides in vitro evidence for
inhibition of FtsZ, a protein that is key to bacterial cell division.
FtsZ assembles into a contractile ring (called the Z-ring) at the
midcell site of the future septum [15]. FtsZ is highly conserved
among bacteria and is a prokaryotic homologue of eukaryotic
tubulin [16,17]. The Z-ring is formed of protofilaments of
polymerised FtsZ subunits. FtsZ, like eukaryotic tubulin, is a
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formation is the earliest known step in bacterial cytokinesis. The
mechanisms involved in Z-ring contraction are unclear, but FtsZ
assembly into the Z-ring is essential to cell division and crucial to
the recruitment of other division proteins including FtsA, ZipA,
FtsK, FtsQ, AmiC and EnvC [18,19]. Because of its vital role in
cell division and its high level of conservation, FtsZ is a desirable
target for antibacterial drug development. Several inhibitors have
been found to date and these include both synthetic and natural
products [20–25].
Previous studies on the mode of action of berberine were mainly
biochemical and included NMR spectroscopy, FtsZ polymerisa-
tion and GTPase activity assays, fluorescence and electron
microscopy. It was shown that berberine binds to FtsZ with high
affinity, inhibits FtsZ assembly and its GTPase activity in vitro.
Berberine causes cell elongation, which is an expected effect of cell
division inhibition. However, cell elongation can be caused by
other factors such as DNA damage and induction of the bacterial
SOS response. Therefore, the antibacterial mode of action of
berberine requires further elucidation.
There is evidence for both DNA binding and FtsZ inhibition as
mechanisms that could explain the antibacterial activities of
berberine. Both possibilities are supported by extensive in vitro
data, but cellular and genetic evidence is lacking. Here we
attempted to test both of these possible mechanisms in live,
growing cells through functional assays. To test whether berberine
binds and damages DNA, an E. coli SOS response reporter strain
was used to report damage caused by berberine in growing cells.
Also, an SOS response-negative strain was used to establish
whether the cell elongation effect of berberine treatment is
dependent on a functional SOS response system. To test whether
berberine inhibits FtsZ, we tested the effects of berberine on FtsZ
localisation and Z-ring assembly in vivo. Also, we used two types of
RNA silencing to reduce ftsZ expression. RNA silencing is a
powerful research tool that enables conditional and titratable
expression reduction of specific genes and thus aids functional
analyses. Here, we applied selective RNA silencers, based both on
expressed antisense RNA and peptide nucleic acids (PNA),
designed to target ftsZ mRNA [26] and also tested the effects of
over-expression of ftsZ on susceptibility to berberine. The findings
are consistent with berberine acting as an FtsZ inhibitor.
Materials and Methods
Bacteria, growth conditions and RNA silencing
E. coli wild-type strain K-12 in Mueller Hinton Broth (MHB,
Fluka, Germany) was used for PNA (Panagene, Korea) studies.
Overnight E. coli cultures were standardised by OD550 readings to
approximately 10
5 cfu/ml and then 20 ml was used as inoculum in
each well of a 96-well plate (Costar, UK). PNA concentrations (0–
2 mM) were optimised for a titration in growth inhibition.
Overnight cultures of derivatives of TOP10 E. coli (Invitrogen,
UK) carrying plasmids expressing antisense sequences (Table 1)
were standardised as above. Antisense expression was induced by
IPTG (0, 20, 40 or 70 mM) added to MHB supplemented with
chloramphenicol (30 mg/ml). For antisense PNA treatment and
IPTG induction, PNA (Table 2) or IPTG in aqueous solution was
deposited into wells of a 96-well plate before the addition of 20 ml
E. coli in liquid culture to a final volume of 200 ml (for a final
10
4 cfu/ml). Bacterial cultures were grown in a Bio-Tek Power-
Wave X340I spectrophotometer at 37uC with agitation every
5 min. Growth was monitored by OD550 readings every 5 min.
For ftsZ over-expression experiments, E. coli strain DH5a carrying
plasmid pBAD-ftsZ (Table 1) was grown as described above with a
Figure 1. Chemical structures of antibacterial compounds used
in this study.
doi:10.1371/journal.pone.0013745.g001
Table 1. Plasmids used in this study.
Plasmid Relevant features Purpose
Antisense target location*
and length Reference/source
pHNZ pHN678 derivative, IPTG-inducible
promoter (Ptrc), Cam
R, ftsZ
antisense insert
Inducible expression
of ftsZ antisense
253 to +76 of ftsZ (129 nt.) [26]
pHN682 pHN678 derivative, IPTG-inducible
promoter (Ptrc), Cam
R, fabI antisense
insert
Inducible expression
of fabI antisense
274 to +86 of fabI (160 nt.) [51]
pLAU80 L-arabinose-inducible promoter
PBAD, ftsZ-yfp fusion, Amp
R
Inducible expression
of ftsZ-yfp fusion
n/a [49]
pBAD-ftsZ L-arabinose-inducible promoter
(PBAD), ftsZ ORF, Amp
R
Inducible over-expression
of ftsZ
n/a [26]
*antisense target locations are indicated relative to the start codon.
doi:10.1371/journal.pone.0013745.t001
Table 2. Structure of PNA used in this study.
PNA Sequence Target
Target location*
and length
Reference/
source
Ec326 (KFF)3K-eg1-
tcaaacatag
ftsZ 22t o+8 (10 nt.) [26]
Ec107 (KFF)3K-eg1-
cccatagctt
fabI 25t o+5 (10 nt.) [52]
*antisense target locations are indicated relative to the start codon.
doi:10.1371/journal.pone.0013745.t002
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formed in triplicate.
Minimum Inhibitory Concentration (MIC) determination
Berberine hemisulphate (Alexis Biochemicals, CA), triclosan
(Ciba AG, Switzerland) and mitomycin C (Roche, UK) were
added in a series of dilutions to growth medium containing
approximately 10
4 cfu/ml of bacteria. MIC was scored as the
lowest concentration of an antimicrobial compound at which no
growth of the tested E. coli strain was observed after 18 hours of
incubation in a 96-well plate prepared as described above.
E. coli SOS response studies
E. coli strain SS996 (Table 3) was grown for 18 hours in a 96-
well plate in a Bio-Tek PowerWave X340I spectrophotometer as
described above, and levels of GFP fluorescence were measured in
a Spectramax M2 (Molecular Devices, CA) spectrophotometer
using 488 nm (excitation) and 520 nm (emission) filters.
Table 3. Escherichia coli strains used in this study.
Strain
Relevant
genotype
Relevant
features Purpose
Berberine
MIC (mM)
Reference/
source
K-12
(MG-1655)
n/a wild-type
strain
PNA
silencing
studies
1.5 Coli Genetic
Stock Center
KG22 n/a n/a expression
of ftsZ-yfp
fusion
4[ 4 9 ]
SS996 Dattl::
sulApV
gfp-mut2,
sulB103
sulA
promoter-
gfp fusion,
ftsZ allele
insensitive
to SulA
SOS
response
studies
4[ 2 9 ]
KP7600 W3110
derivative
miniTn10,
Kan
R
wild-type
strain
reference
strain
for JD26285
4.5 [50]
JD26285 DsulA773::
kan,
KP7600
derivative,
Kan
R
negative
for SOS-
mediated
cell division
inhibition
(sulA
2)
expression
of
antisense
RNA; cell
morphology
studies
4.5 [50]
DH5a n/a n/a cloning and
expression
of ftsZ
2.5 Invitrogen
doi:10.1371/journal.pone.0013745.t003
Figure 2. Bacterial SOS response in the presence of berberine.
The doses of each compound were chosen as indicated percentage of
the MIC (4 mM, 15 nM and 400 nM for berberine, mitomycin C and
triclosan, respectively). Mitomycin C and triclosan were included as
positive and negative controls for SOS induction. The Relative
Fluorescence Units (RFUs) indicate the level of SOS reporter expression
in the SOS-negative E. coli strain SS996.
doi:10.1371/journal.pone.0013745.g002
Figure 3. Effect of berberine on E. coli morphology. Bacteria
(wild-type and the SOS-negative strain) were either untreated or treated
with 1.5 mM berberine. Scale bars are 10 mm.
doi:10.1371/journal.pone.0013745.g003
Figure 4. Z-ring formation and cell morphology in berberine-
treated E. coli. Representative cells untreated and treated with 3 mM
berberine; FtsZ was tagged with YFP and bacterial DNA was visualised
through staining with DAPI. Scale bars are 10 mm.
doi:10.1371/journal.pone.0013745.g004
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Overnight cultures of E. coli KP7600 (wild-type) and JD26285
(sulA::Tn5 SOS
2 mutant, see Table 3) were grown in MHB,
refreshed 1:50 with fresh MHB medium and then either
untreated or treated with different concentrations of berberine
hemisulphate (1.5, 2.5 and 3 mM) for 2 hours at 37uC and
200 rpm. The cells were viewed by fluorescence microscopy at
6306 total magnification on a DM 4000B fluorescence
microscope (Leica, Germany).
For Z-ring formation studies, E. coli strain KG22-pLAU80 (a
gift from Professor Kenn Gerdes and Ms Elisa Galli, Newcastle
University) containing plasmid pLAU80 (Table 1) carrying a ftsZ-
yfp fusion was used. An overnight culture was refreshed as above
and treated with 3 mM berberine for one hour. 0.2% L-arabinose
was added in order to induce production of FtsZ-YFP. After one
hour, induction was stopped by addition of 0.2% glucose and the
cells were allowed to grow for another 30 minutes. The culture was
then harvested by centrifugation; washed three times in an equal
volume of 1 6 PBS in order to remove the residues of growth
medium and berberine, and re-suspended in 1 ml of 1 6 PBS.
DAPI (Sigma, UK) was added to a final concentration of 1 mM,
cells were incubated at room temperature for 10 mins, washed
three times with 1 6 PBS and viewed under a fluorescent
microscope as above. Images were captured and processed using
Leica IM 500 and Adobe Photoshop Elements software.
Fractional Inhibitory Concentration Indices (FICIs)
calculations for synergy studies
Fractional Inhibitory Concentrations (FICs) for berberine and
the applied gene silencers were calculated as follows:
FICberberine~
MICberberinezsilencer
MICberberine
FICsilencer~
MICsilencerzberberine
MICsilencer
FICIs were determined by adding the FIC values for berberine
and each silencer:
FICI~FICberberinezFICsilencer
The FICIs represent the level of paired interaction, where
‘synergy’ is defined by values #0.5 and ‘no interaction’ by values
.0.5–4.0 [27]. The combinations of berberine and silencer were
tested in triplicate.
Statistical analysis
Statistical analyses of R
2 for correlation, mean 6 SD
calculations and ANOVA were carried out using MS Excel 2007.
Results
Berberine does not induce a significant SOS response in
E. coli
Berberine has been reported to be a DNA ligand and some of
the effects it has on bacterial cells, particularly cell elongation
could be explained by DNA binding/damage and subsequent
induction of the bacterial SOS response. Hence, to test the
possibility that the mode of action of berberine is a result of its
ability to bind DNA, E. coli SS996, an SOS response indicator
strain, was used. This strain contains a fusion of the promoter of
the SOS response division inhibitor gene sulA with gfp and also an
allele of FtsZ that is insensitive to SulA (SulB103) [28]. The strain
is negative for SOS-induced cell division inhibition, but the
presence of the sulAp-gfp fusion allows a measurement of the level
of fluorescence, and thereby SOS response induction in the cell
caused by a test compound [29]. E. coli SS996 was grown with the
addition of different amounts of berberine. For comparison, equal
amounts of mitomycin C and triclosan (as a respective percentage
of the MIC of each compound which did not cause a significant
growth inhibition) were used. Mitomycin C, a potent DNA
crosslinker used as an anti-tumour agent, was applied as a positive
control. Triclosan, a specific inhibitor of the enoyl-acyl carrier
protein reductase (FabI) involved in fatty acid biosynthesis, was
used as a negative control. Relative fluorescence of E. coli SS996
treated with the three compounds is presented in Figure 2. Both
triclosan and berberine induced virtually no SOS response at
doses of up to 4% of their MIC. In contrast, mitomycin C caused a
significant level of fluorescence in this dose range, indicating strong
induction of the SOS response. The results suggest that berberine
induction of the SOS response in bacteria is very low relative to
mitomycin C.
Berberine treatment results in cell elongation in an SOS
response-negative strain
If berberine causes cell elongation through inhibition of the
bacterial division protein FtsZ and not induction of the SOS
r e s p o n s e ,t h e nb e r b e r i n es h o u l da l s oc a u s ee l o n g a t i o ni na nS O S
response-negative strain. To test this possibility, E. coli strain
JD26285 (SulA
2, SOS-negative) and KP7600 (parent strain,
wild-type, Table 3) were cultured either with or without sub-
inhibitory concentrations of berberine and examined using
fluorescence microscopy. Untreated cells exhibited normal
morphology, whereas berberine-treated cells of both strains
were significantly elongated (Figure 3). Thus, berberine also
causes cell elongation in a strain lacking the SOS response.
Together these results argue strongly against the hypothesis that
the antimicrobial effect of berberine is due to DNA binding
activity.
Berberine inhibits Z-ring formation in vivo
To study the effect of berberine on Z-ring formation, we
applied an E. coli strain KG22 carrying pLAU80 (Table 1), which
contains an ftsZ-yfp fusion. In the absence of berberine, clear Z-
rings were visible in many of the observed cells (Figure 4), and
some cells exhibited multiple Z-rings and an elongated structure,
presumably due to over-abundance or dysfunction of the FtsZ-
GFP fusion [30,31]. Most cells displayed one or more Z-rings.
Addition of 3 mM berberine heavily perturbed the formation of
the Z-rings. The fluorescence was evenly distributed in the
cytoplasm of the berberine-treated bacteria, and very few cells
displayed the Z-rings. These findings also support the hypothesis
that FtsZ inhibition is the main mode of action of berberine in
bacteria.
Figure 5. Effect of expressed antisense RNA-mediated ftsZ silencing on E. coli growth and susceptibility to berberine. (A) Growth
curves for the SOS-negative strains carrying the control and anti-ftsZ plasmids. Antisense expression was induced by a range of IPTG concentrations
(0–70 mM) and cells were treated with the indicated concentrations of berberine. (B) Regression analysis of IPTG concentration and the MIC of
berberine in both strains.
doi:10.1371/journal.pone.0013745.g005
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To examine the mode of action of berberine using gene
expression titration experiments, we applied two different,
established methods of RNA silencing: expressed antisense RNA
and antisense PNA. The specificity of these methods has been
examined in several studies and validated silencers have been
reported for the E. coli ftsZ gene [26]. E. coli growth was monitored
both in the presence and absence of berberine, and with or
without ftsZ silencing using PNA and antisense RNA. This strategy
was based on the principle that lowering (but not eliminating) the
expression of a target gene using antisense technology would cause
the bacteria to be more susceptible to an antimicrobial compound
targeting the product of that gene. In the case of expressed
antisense RNA, E. coli SOS-negative strain JD26285 carrying
either plasmid pHNZ (anti-ftsZ), or pHN682 (anti-fabI antisense,
control) were grown in the presence of a range of berberine and
IPTG (inducer for the antisense RNA expression) concentrations.
The growth curves and MICs for different levels of anti-ftsZ RNA
expression are presented in Figure 5. Addition of IPTG had a clear
inhibitory effect on the growth of cells due to silencing of a growth-
essential gene. Silencing of ftsZ prolonged the lag phase and
lowered the final OD. Moreover, silencing of ftsZ caused the
bacteria to be more sensitive to berberine. Most importantly, upon
induction of antisense anti-ftsZ RNA expression, bacterial growth
was completely inhibited at a lower concentration of berberine.
Silencing of ftsZ expression resulted in a reduction of the MIC of
berberine from 4.5 mM without IPTG to 2 mM for 70 mM IPTG,
whereas the control strain was not affected by IPTG (MICs were
the same within the applied range of IPTG concentrations). In
addition, the FIC indices revealed synergy between anti-ftsZ RNA
expression and berberine treatment (FICI=0.23, Fig. 5) and
suggest no interaction between berberine addition and silencing of
the control gene fabI (FICI=0.78).
Addition of anti-ftsZ PNA had an effect on bacterial growth that
was similar to that observed with expression of anti-ftsZ RNA. In
this case wild-type K-12 E. coli strain and PNA targeting ftsZ
(Ec326) and fabI (Ec107, control) were utilised. Again, bacteria
were sensitised to berberine when the ftsZ gene was silenced by the
PNA; the MIC of berberine was reduced from 1.75 mM (no PNA
added) to 0.25 mM (2 mM Ec326 added). As a control, silencing of
fabI had no effect on cell susceptibility to berberine. Also, FIC
indices suggest synergy between silencing of ftsZ and berberine
treatment (FICI=0.25) compared with FICI=1 for silencing of
fabI. Growth curves and linear regression analysis of MIC is shown
in Figure 6.
The results from both silencing approaches support the
hypothesis that berberine targets the bacterial division protein
FtsZ. For comparison, the MICs of berberine for each of the E. coli
strains used in this study are presented in Table 3.
Antagonism between ftsZ over-expression and berberine
effect on bacterial growth
To establish whether over-expression of ftsZ increases bacterial
resistance to berberine, we used E. coli DH5a carrying plasmid
pBAD-ftsZ, and DH5a without a plasmid was used to prove a
control having basal ftsZ expression. Relative growth rates were
calculated as DOD/Dt, and cultures were scored after
Dt=10 hours, as further ftsZ over-expression was growth-inhibi-
tory (data not shown). In the case of the strain over-expressing ftsZ,
without the addition of berberine, an increase in L-arabinose
concentration caused a growth rate decrease. This was because
ftsZ over-expression is toxic to the cell, presumably due to its
crucial and multi-faceted role in cell division [32,26,33,34]. In the
presence of arabinose, the addition of berberine increased
bacterial growth (Figure 7); the cultures exhibited a moderate
increase in the relative growth rate with increasing amounts of L-
arabinose. In the case of the control strain, addition of L-arabinose
did not rescue bacterial growth from inhibition by berberine.
These results indicate that ftsZ over-expression antagonised the
toxic effect of berberine, further suggesting that berberine targets
FtsZ.
Discussion
The plant-derived isoquinoline alkaloid berberine has a long
history of use as an antimicrobial agent. Also, it has been shown to
suppress the growth of a variety of tumour cells, and is effective in
certain types of diabetes or cardiovascular conditions [6,35–44].
Understanding the mechanism(s) of action of berberine is of
significant interest and requires further studies. Berberine is a
known DNA and RNA binder [45,11,46,47], and recently it was
reported to target the bacterial division protein FtsZ [2]. The
evidence supporting these findings was obtained mainly through
biochemical and biophysical studies. Here, we aimed to test these
two hypotheses for the mode of action of berberine in bacteria
using a molecular genetics approach. Firstly, we investigated the
possibility that the growth inhibitory properties of berberine are
due to its ability to bind to DNA and, therefore, induced bacterial
Figure 6. Effect of PNA-mediated ftsZ silencing on cell growth and susceptibility to berberine in E. coli K-12 strain. (A) Typical growth
curves; cells were grown in the presence one of two different PNAs: Ec326 (anti-ftsZ) or Ec107 (anti-fabI, negative control) in a range of concentrations
(0–2 mM) and treated with the indicated concentrations of berberine. (B) Regression analysis of PNA concentration and the MIC of berberine.
doi:10.1371/journal.pone.0013745.g006
Figure 7. Over-expression of ftsZ and its effect on E. coli growth
in the presence and absence of berberine. Bacteria (E. coli DH5a
carrying plasmid pBAD-ftsZ) were induced using a concentration range
of L-arabinose (0–0.01%) to allow over-expression of the FtsZ protein
and grown in the absence or presence of berberine. The growth rate in
the absence of L-arabinose or berberine was set as 1. As a control, E. coli
DH5a without the plasmid was treated with berberine in the same
range of L-arabinose concentrations.
doi:10.1371/journal.pone.0013745.g007
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berberine did not cause a significant level of SOS response in
the indicator E. coli strain SS996 relative to the positive control.
This result is consistent with an earlier study of berberine using the
SOS chromotest, which showed that the compound is not a potent
genotoxic or mutagenic agent [48]. Furthermore, berberine
caused cell elongation in an SOS-negative strain, as it did in the
wild-type strain. Fluorescence microscopy showed berberine to
cause disruptions of Z-ring formation in vivo. These findings
suggested that FtsZ is the main target for berberine in bacteria. To
further test this hypothesis, we studied the relationship between the
cellular abundance of the putative target and the effect of
berberine on bacterial growth; ftsZ expression was titrated using
antisense and over-expression tools. Lowering the expression of
ftsZ resulted in increased susceptibility of the bacteria to berberine
and also in a decrease in the MIC. In the control assay, upon
silencing of another essential gene, fabI, sensitisation to berberine
was not observed. Furthermore, over-expression of ftsZ, despite
high level of toxicity, rescued the growth of berberine-treated cells.
In conclusion, the data argue against DNA binding/damage as
the primary mechanism of action of berberine, and argue strongly
for inhibition of FtsZ as the primary target for berberine in
bacteria. This does not exclude the possibility that berberine can
act in part through DNA or RNA binding or by inhibition of other
cell division proteins such as FtsA or ZipA. Several possible
mechanisms of action of berberine in mammalian cells have been
proposed. Nevertheless, the evidence that berberine inhibits FtsZ
clarifies how this compound exerts an antibacterial effect.
Berberine is used in traditional Chinese, Native American and
Western medicine, and it may be possible to develop berberine
analogues with improved potency. Finally, the RNA silencing
strategies applied in this study provide a means to rapid
identification of other FtsZ inhibitors.
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